These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 17622118

  • 21. Biodegradable microparticles for sustained release of a new GnRH antagonist--part I: Screening commercial PLGA and formulation technologies.
    Schwach G, Oudry N, Delhomme S, Lück M, Lindner H, Gurny R.
    Eur J Pharm Biopharm; 2003 Nov; 56(3):327-36. PubMed ID: 14602174
    [Abstract] [Full Text] [Related]

  • 22. Preparation, characterization, and in vivo evaluation of salmon calcitonin microspheres.
    Dani BA, DeLuca PP.
    AAPS PharmSciTech; 2001 Oct 17; 2(4):22. PubMed ID: 14727859
    [Abstract] [Full Text] [Related]

  • 23. Impurity formation studies with peptide-loaded polymeric microspheres Part II. In vitro evaluation.
    Murty SB, Na DH, Thanoo BC, DeLuca PP.
    Int J Pharm; 2005 Jun 13; 297(1-2):62-72. PubMed ID: 15885939
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Recombinant human bone morphogenetic protein-2 binding and incorporation in PLGA microsphere delivery systems.
    Schrier JA, DeLuca PP.
    Pharm Dev Technol; 1999 Jun 13; 4(4):611-21. PubMed ID: 10578516
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Preparation of ONO-1301-loaded poly(lactide-co-glycolide) microspheres and their effect on nerve conduction velocity.
    Hazekawa M, Sakai Y, Yoshida M, Haraguchi T, Morisaki T, Uchida T.
    J Pharm Pharmacol; 2011 Mar 13; 63(3):362-8. PubMed ID: 21749383
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Sodium fusidate-poly(D,L-lactide-co-glycolide) microspheres: preparation, characterisation and in vivo evaluation of their effectiveness in the treatment of chronic osteomyelitis.
    Cevher E, Orhan Z, Sensoy D, Ahiskali R, Kan PL, Sağirli O, Mülazimoğlu L.
    J Microencapsul; 2007 Sep 13; 24(6):577-95. PubMed ID: 17654177
    [Abstract] [Full Text] [Related]

  • 40. Porcine insulin biodegradable polyester microspheres: stability and in vitro release characteristics.
    Shao PG, Bailey LC.
    Pharm Dev Technol; 2000 Sep 13; 5(1):1-9. PubMed ID: 10669912
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.